39796-49-1

Basic information

• Product Name: 2-Benzylaminoacetamide
• Synonyms: 2-BENZYLAMINO-ACETAMIDE;N-benzyl-glycine amide
• CAS NO: 39796-49-1
• Molecular Formula: C₉H₁₂N₂O
• Molecular Weight: 164.2
• Product Categories: pharmacetical
• Mol File: 39796-49-1.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 333 °C at 760 mmHg
• Flash Point: 155.2 °C
• Appearance: /
• Density: 1.106g/cm³
• Vapor Pressure: 0.000141mmHg at 25°C
• Refractive Index: 1.554
• CAS DataBase Reference: 2-Benzylaminoacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Benzylaminoacetamide(39796-49-1)
• EPA Substance Registry System: 2-Benzylaminoacetamide(39796-49-1)

Safety Data

• Hazardous Substances Data: 39796-49-1(Hazardous Substances Data)

Usage

General Description

2-Benzylaminoacetamide is a chemical compound with the molecular formula C10H13N3O. It is a derivative of acetamide with a benzylamine group attached to the nitrogen atom. 2-Benzylaminoacetamide has been studied for its potential pharmaceutical properties and is known to exhibit anti-inflammatory and antimicrobial activities. It has also been investigated for its potential use as a building block in organic synthesis. 2-Benzylaminoacetamide shows promise as a versatile starting material for the synthesis of various biologically active molecules and may have potential applications in drug discovery and development.

InChI:InChI=1/C9H12N2O/c10-9(12)7-11-6-8-4-2-1-3-5-8/h1-5,11H,6-7H2,(H2,10,12)

Upstream product

• 100-46-9 benzylamine 
• 79-07-2 Chloroacetamide 
• 1668-10-6 glycinamide hydrochloride 
• 100-52-7 benzaldehyde 
• 63086-36-2 2-(benzylamino)acetonitrile hydrochloride 

Downstream Products

• 114981-09-8 1-benzyl-3-(hydroxymethyl)imidazolidin-4-one 
• 153393-25-0 methyl 1-benzyl-4-oxo-2-imidazolidinepropanoate 
• 345945-45-1 6-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-hexanoic acid benzyl-carbamoylmethyl-amide 
• 874657-86-0 2-{N-benzyl-N-[(methoxycarbonyl)methyl]amino}acetamide 
• 871893-10-6 N,N-di(carbamoylmethyl)benzylamine 
• 114981-16-7 3-benzyl-5-oxo-1-imidazolidineacetamide 
• 114981-11-2 1-benzyl-4-imidazolidinone 
• 114981-14-5 ethyl 3-benzyl-5-oxo-1-imidazolidineacetate 
• 86451-32-3 N-Benzyl-N-aminocarbonylmethyl-6-aminohexanamide 
• 86451-33-4 Methyl N-(6-aminohexanoyl)-N-benzylaminomethylcarbamate 
• 86451-34-5 N-(6-Aminohexyl)-N-benzyl-N'-methylmethylenediamine 
• 1207092-47-4 1-benzyl-4-chloro-1H-imidazole-5-carbaldehyde 

Relevant articles and documents

Carbohydrates as efficient catalysts for the hydration of α-amino nitriles

Directed hydration of α-amino nitriles was achieved under mild conditions using simple carbohydrates as catalysts exploiting temporary intramolecularity. A broadly applicable procedure using both formaldehyde and NaOH as catalysts efficiently hydrated a variety of primary and secondary susbtrates, and allowed the hydration of enantiopure substrates to proceed without racemization. This work also provides a rare comparison of the catalytic activity of carbohydrates, and shows that the simple aldehydes at the basis of chemical evolution are efficient organocatalysts mimicking the function of hydratase enzymes. Optimal catalytic efficiency was observed with destabilized aldehydes, and with difficult substrates only simple carbohydrates such as formaldehyde and glycolaldehyde proved reliable.

SUBSTITUTED (THIOPHENYL-CARBONYL)IMIDAZOLIDINONES, AND USE THEREOF

The present invention relates to novel substituted (thiophenyl-carbonyl)imidazolidinones, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.

SUBSTITUTED (PYRAZOLYLCARBONYL)IMIDAZOLIDINONES AND THEIR USE

The present invention relates to novel substituted (pyrazolylcarbonyl)imidazolidinones, methods for their preparation, their use for the treatment and/or prophylaxis of diseases, as well as their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of retroviral diseases, in humans and/or animals.